Catalyst Wire Dossier Catalyst Wire Dossier

Investigational neurological disorder drug (name undisclosed)

· Idorsia Pharmaceuticals Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Investigational neurological disorder drug (name undisclosed), covering 2018-07-10 to 2018-07-10. Get the full timeline:

Most recent: Clinical Trial Update: First-in-man Study of Single and Multiple Ascending Doses of a New Drug for Neurological Disorders [Phase 1]

See pricing